HRES. 803
CommitteeUrging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
Updated 2026-04-19
Legislative Impact
Limited Policy Signal
32
Momentum Score
Low Momentum
0
Urges the Food and Drug Administration Director to reevaluate the safety of chemical abortion drugs using recent independent studies
- Direct reevaluation of chemical abortion drugs
